Literature DB >> 6237706

A comparison of dimaprit, nordimaprit, methylamine and chloroquine as inhibitors of mitogen-induced lymphocyte activation.

M M Dale, R Ladd.   

Abstract

Methylamine and chloroquine both 'lysosomotropic' agents (i.e. agents which sequester in lysosomes) caused a dose-related inhibition of mitogen-induced lymphocyte activation in the concentrations which have previously been shown to increase the pH of lysosomes. The dose-response curves of inhibition of mitogen-induced lymphocyte activation for chloroquine and methylamine are very steep and are similar to the dose-response curves obtained with dimaprit and nordimaprit, but very different from the flat dose-response curves previously described for histamine. Approximate IC50 values were methylamine 6.4 mM, dimaprit 0.13 mM, nordimaprit 0.03 mM and chloroquine 18 microM. It is suggested that the mechanism of action of methylamine and chloroquine may be related to their lysosomotropic action and consequent interference with ligand-receptor processing, and that dimaprit and nordimaprit but not histamine may act by a similar mechanism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237706      PMCID: PMC1987178          DOI: 10.1111/j.1476-5381.1984.tb10145.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  LYSOSOMES IN DIVIDING CELLS, WITH SPECIAL REFERENCE TO LYMPHOCYTES.

Authors:  A C ALLISON; L MALLUCCI
Journal:  Lancet       Date:  1964-12-26       Impact factor: 79.321

2.  SUPPRESSION OF IN VITRO LYMPHOCYTE RESPONSES BY CHLOROQUINE.

Authors:  D HURVITZ; K HIRSCHHORN
Journal:  N Engl J Med       Date:  1965-07-01       Impact factor: 91.245

3.  Histamine suppression of human lymphocyte responses to mitogens.

Authors:  S R Wang; B Zweiman
Journal:  Cell Immunol       Date:  1978-03-01       Impact factor: 4.868

4.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Authors:  S Ohkuma; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

Review 5.  Commentary. Lysosomotropic agents.

Authors:  C de Duve; T de Barsy; B Poole; A Trouet; P Tulkens; F Van Hoof
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

6.  Effects of lysosomotropic monoamines, diamines, amino alcohols, and other amino compounds on protein degradation and protein synthesis in isolated rat hepatocytes.

Authors:  P O Seglen; P B Gordon
Journal:  Mol Pharmacol       Date:  1980-11       Impact factor: 4.436

7.  Effect of methylamine on internalization, processing and biological activation of epidermal growth factor receptor.

Authors:  H J Michael; S Bishayee; M Das
Journal:  FEBS Lett       Date:  1980-08-11       Impact factor: 4.124

8.  The inhibitory action of some antimalarial drugs and related compounds on the hexokinase of yeast and of Plasmodium berghei.

Authors:  D M FRASER; W O KERMACK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

9.  Inhibition of lymphocyte transformation by mepacrine and chloroquine.

Authors:  D G Trist; M Weatherall
Journal:  J Pharm Pharmacol       Date:  1981-07       Impact factor: 3.765

10.  Mitogenic hormone-induced intracellular message: assay and partial characterization of an activator of DNA replication induced by epidermal growth factor.

Authors:  M Das
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

View more
  2 in total

1.  Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy.

Authors:  J K French; N P Hurst; M L O'Donnell; W H Betts
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

2.  Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays.

Authors:  Mohamed A Kamal; William J Jusko
Journal:  J Clin Pharmacol       Date:  2004-09       Impact factor: 3.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.